טוען...
Hypercalcemia and acute kidney injury induced by eldecalcitol in patients with osteoporosis: a case series of 32 patients at a single facility
Background: Eldecalcitol (ELD) is an active vitamin D(3) analog that is widely used in Japan for the treatment of osteoporosis. The most common adverse drug reaction of ELD is hypercalcemia. However, few reports have focused on acute kidney injury (AKI) associated with ELD-induced hypercalcemia. Mat...
שמור ב:
| הוצא לאור ב: | Ren Fail |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6442105/ https://ncbi.nlm.nih.gov/pubmed/30909788 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/0886022X.2019.1578667 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|